Endometrial cancer is one of the most common gynaecological cancers in both United States and Russian Federation, rate continues to rise. Although early-stage endometrial associated with a favourable 5-year survival (96%), this patients distant metastases accounts for only 18%. A combination paclitaxel carboplatin standard first-line therapy advanced, recurrent metastatic carcinoma. Pembrolizum...